Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. New treatment approved for certain high-risk AML

    ... fever with low white blood cell count (febrile neutropenia ), rash, swelling of the tissues (edema), nausea, inflammation ...

    Article last updated 08/30/2017 - 7:18am.

  2. Flu Season Update

    ... patients who have low white blood cell counts ( neutropenia ) should discuss any fevers following the vaccine with their ... shot. For people with a low white blood cell count (neutropenia):  It is important to know that the flu shot can cause a ...

    Facts for Life last updated 02/01/2018 - 3:49pm.

  3. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

    ... been reported in a minority of patients with congenital neutropenia and aplastic anemia (AA). The bone marrow (BM) ...

    Research Article last updated 11/25/2014 - 9:57am.

  4. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.

    ... was considerable, mainly due to prolonged absolute neutropenia , which occurred regardless of pre-therapy blood counts and ...

    Research Article last updated 10/07/2014 - 8:33am.

  5. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    ... was considerable, mainly due to prolonged absolute neutropenia , which occurred regardless of pre-therapy blood counts and ...

    Research Article last updated 09/24/2014 - 10:17am.

  6. An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes

    ... events >30% included diarrhea, fatigue, nausea, febrile neutropenia , and stomatitis. Results suggest modest activity in AML, ...

    Research Article last updated 08/04/2014 - 8:28am.

  7. Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia

    ... (OS) durations were 13.2, 19.1, and 14.9 months. Neutropenia was the most common grade 3-4 adverse event. These results ...

    Research Article last updated 05/22/2014 - 9:28am.

  8. Myelodysplastic syndromes: a challenging disease for patients and physicians

    ... the treatment carries a high risk of rapidly developing neutropenia and thrombocytopenia . Several promising drugs are ...

    Research Article last updated 07/31/2012 - 1:58pm.

  9. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes

    ... MDS can present with varying degrees of anemia , neutropenia , and thrombocytopenia , and at presentation can range ...

    Research Article last updated 07/31/2012 - 1:03pm.

  10. The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes

    ... management, including dose modifications for neutropenia and thrombocytopenia , and venous thromboembolism ...

    Research Article last updated 11/16/2011 - 2:10pm.